|
Nov 14
|
Declining Stock and Decent Financials: Is The Market Wrong About Voyager Therapeutics, Inc. (NASDAQ:VYGR)?
|
|
Nov 13
|
Q3 2024 Voyager Therapeutics Inc Earnings Call
|
|
Nov 13
|
Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...
|
|
Nov 12
|
Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates
|
|
Nov 12
|
Voyager Therapeutics: Q3 Earnings Snapshot
|
|
Nov 12
|
Voyager Reports Third Quarter 2024 Financial and Operating Results
|
|
Oct 7
|
Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength?
|
|
May 16
|
Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease
|
|
May 14
|
Q1 2024 Voyager Therapeutics Inc Earnings Call
|
|
May 14
|
Voyager Therapeutics Inc (VYGR) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
|
|
May 13
|
Voyager Therapeutics (VYGR) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 13
|
Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
|
|
May 8
|
Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
|
|
May 6
|
Voyager Therapeutics' (NASDAQ:VYGR) three-year earnings growth trails the splendid shareholder returns
|
|
May 6
|
Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast
|
|
May 3
|
Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
|
|
May 2
|
Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates
|
|
Apr 22
|
Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
|
|
Apr 16
|
Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
|
|
Apr 9
|
Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
|